UBS Asset Management Americas Inc. raised its position in HCP Inc. (NYSE:HCP) by 2.6% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 2,567,866 shares of the real estate investment trust’s stock after buying an additional 64,759 shares during the period. UBS Asset Management Americas Inc.’s holdings in HCP were worth $97,451,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of HCP. Zacks Investment Management boosted its stake in HCP by 3.1% in the second quarter. Zacks Investment Management now owns 407,096 shares of the real estate investment trust’s stock worth $14,403,000 after buying an additional 12,219 shares during the last quarter. APG Asset Management N.V. boosted its stake in HCP by 40.9% in the third quarter. APG Asset Management N.V. now owns 480,262 shares of the real estate investment trust’s stock worth $18,226,000 after buying an additional 139,500 shares during the last quarter. Hanlon Investment Management Inc. acquired a new stake in HCP during the second quarter worth $4,763,000. Daiwa Securities Group Inc. boosted its stake in HCP by 8.0% in the second quarter. Daiwa Securities Group Inc. now owns 16,604,480 shares of the real estate investment trust’s stock worth $587,467,000 after buying an additional 1,223,911 shares during the last quarter. Finally, LGT Capital Partners LTD. boosted its stake in HCP by 16.5% in the third quarter. LGT Capital Partners LTD. now owns 514,400 shares of the real estate investment trust’s stock worth $19,521,000 after buying an additional 72,960 shares during the last quarter. 92.07% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Shares of HCP Inc. (NYSE:HCP) opened at 29.38 on Tuesday. The stock’s market capitalization is $13.75 billion. HCP Inc. has a 1-year low of $22.87 and a 1-year high of $36.82. The firm’s 50-day moving average price is $30.73 and its 200 day moving average price is $32.83.

HCP (NYSE:HCP) last released its quarterly earnings data on Tuesday, November 1st. The real estate investment trust reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. HCP had a negative net margin of 1.16% and a negative return on equity of 0.32%. The company earned $654.30 million during the quarter, compared to the consensus estimate of $634.11 million. During the same quarter in the prior year, the firm posted $0.79 earnings per share. Equities research analysts expect that HCP Inc. will post $2.74 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 25th. Shareholders of record on Thursday, November 10th were paid a $0.37 dividend. The ex-dividend date was Tuesday, November 8th. This represents a $1.48 annualized dividend and a yield of 5.04%. HCP’s dividend payout ratio is presently -1,850.00%.

TRADEMARK VIOLATION WARNING: This story was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The original version of this story can be read at http://www.dailypolitical.com/2016/11/29/ubs-asset-management-americas-inc-raises-position-in-hcp-inc-hcp.html.

HCP has been the subject of a number of recent analyst reports. BTIG Research initiated coverage on HCP in a research report on Thursday, August 25th. They issued a “neutral” rating for the company. Vetr cut HCP from a “strong-buy” rating to a “buy” rating and set a $32.83 price target for the company. in a research report on Tuesday, November 15th. Mizuho raised HCP from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $31.00 to $32.00 in a research report on Monday, November 21st. Zacks Investment Research cut HCP from a “buy” rating to a “hold” rating in a research report on Monday, September 26th. Finally, Wells Fargo & Co. reaffirmed a “hold” rating on shares of HCP in a research report on Sunday, September 4th. Four investment analysts have rated the stock with a sell rating, fourteen have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $34.33.

In other news, insider Darren A. Kowalske sold 2,250 shares of the stock in a transaction dated Wednesday, August 31st. The shares were sold at an average price of $39.20, for a total transaction of $88,200.00. Following the completion of the sale, the insider now owns 9,793 shares in the company, valued at $383,885.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas D. Kirby sold 3,000 shares of the stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $40.24, for a total transaction of $120,720.00. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by company insiders.

HCP Company Profile

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

5 Day Chart for NYSE:HCP

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP Inc. (NYSE:HCP).

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.